Predictive Value of Tumor Mutation Burden for PD-1/PD-L1 Inhibitors Treatment on Non-small Cell Lung Cancer: A Meta-analysis

Predictive Value of Tumor Mutation Burden for PD-1/PD-L1 Inhibitors Treatment on Non-small Cell Lung Cancer: A Meta-analysis

Objective To investigate the relation between TMB and the efficiency of PD-1/PD-L1 inhibitors treatment for non-small-cell lung cancer. Methods Studies were searched from PubMed, Embase, Cochrane Library database, Chinese Biomedical Literature Database and Wanfang Database up to March 25, 2020. RevM...

Full description

Bibliographic Details
Main Authors: SHEN Shijun, WANG Qiaoli, YANG Jinjiang, LI Guojian, LI Mengli, ZHANG Xiaoli, GAN Ping
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
mmunotherapy
meta-analysis
non-small cell lung cancer
pd-1/pd-l1 inhibitors
tumor mutation burden
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.0765.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.0765.htm

Similar Items